Search results | abbott

Reports

Partnering Agreements with Abbott

This report provides all the information you require to better understand Abbott and its partnering interests and activities over the past seven years.

Insights

Abbott Laboratories

Abbott Laboratories is a top pharmaceutical company based in Illinois, USA

Volcano Corporation maybe up for grabs by Medtronic or Abbott Lab

Rumor has it that due to the slow stent market Volcano Corporation may be up for sell which could be bought by Medtronic or Abbott Labs.

Dealtalk: Abbott plans to acquire Johnson & Johnson assets

According to dealtalk, Abbott Laboratories is presently evaluating an asset purchase transaction, whereby, it may acquire certain assets of Johnson & Johnson in Pakistan.

Abbott Laboratories: Company profile

Abbott Laboratories, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years

Pharma partnering with Abbott: Transforming business through partnerships

Abbott Laboratories is a top pharma company active in pharma partnering, licensing and M&A in pharmaceuticals, diagnostics, devices and nutrition

Abbott Laboratories halts M&A in recent years: M&A activity 2005-2013

Abbott Laboratories has announced 13 M&A deals since 2005, with the lead deals being the acquisition of Solvay, KOS Pharmaceuticals, Advanced Medical Optics and Piramal Healthcare

Abbott Laboratories focus on CNS and oncology: Pharma partnering activity 2005-2013

Abbott Laboratories announced over 130 pharma partnering / licensing deals since 2005, with over 25 deals in 2012 alone

Pharma news: Abbott plans to make big acquisitions in Russia

The latest pharma news reports that, the rumored Abbott Laboratories deal could be one of the top three largest acquisitions in the history of Russia’s pharmaceutical market

Abbott Fills Out Leadership Team for its spin-off pharmaceutical comapny, AbbVie

Abbott Laboratories, a big pharmaceutical company unveiled the leadership team for the  proprietary pharmaceutical division that it plans to separate into an  independent company

Deals worth $1.75 billion offer insight into Abbott’s spinoff strategy

Recent acquisitions underscore the Abbott’s determination to augment the new firm’s drug pipeline ahead of the spin, even if it comes at a hefty price with little guarantee the investments will pay off.

Events

Sorry, your search returned no results.


Deals

Abbott to distribute Sekiui’s coagulation testing solutions

Abbott and Sekisui announce an agreement to offer coagulation testing solutions for laboratories worldwide

Zoetis acquires Abbott animal health assets

Zoetis announced an agreement to purchase animal health assets of Abbott for a purchase price of $255 million

Abbott announces acquisition of Topera for $250 million

Abbott has entered into an acquisition agreement to purchase Topera.

ABL and Abbott sign a biotech deal for HIV genotyping analysis

Advanced Biological Laboratories has granted Abbott non-exclusive rights to market ABL’s software suite for HIV genotyping data analysis.

Banyan Biomarkers signs pharma licensing deal with Abbott

Banyan Biomarkers has licensed its intellectual property related to traumatic brain injury (TBI) biomarkers to Abbott for assessment and verification . The terms of the in a pharma licensing agreement were not disclosed.

Abbott signs a biotech deal with US Defense Department

Abbott and the United States Department of Defense announced a collaboration with the intent to develop portable blood tests to help evaluate potential concussions, also called mild traumatic brain injuries (TBIs).

Big pharma, Mylan, buys generic business from Abbott

Mylan, big pharma, will acquire Abbott’s non-U.S. developed markets specialty and branded generics business (“the Assets”) in an all-stock transaction.

Big pharma, Abbott, signs a joint venture with Fonterra

New Zealand’s Fonterra and Abbott, the US big pharma and health care giant are to develop a dairy farm hub in China.

M&A news: Abbott to acquire Veropharm for $495 million

In today’s m&a news, Abbott announced a definitive agreement to acquire Veropharm, a leading Russian pharmaceutical manufacturer.

Big pharma, Abbott acquires CFR Pharma for $2.9 billion

Abbott announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals.

cpbannerad300x150new2gif
rauconbadgejpg
e78banner300x150animgif
cpbannerad300x150new2gif
rauconbadgejpg
e78banner300x150animgif